Speakers

*Speakers confirmed to-date.
Please check back as new speakers are being added.

Co-Chairs

Guy Donatiello

Senior Vice President, Intellectual Property
Endo Pharmaceuticals

Co-Chairs’ Opening Remarks and Recap of Day One

April 30, 2019 • 8:00 am

Pearl T.L. Siew

Senior Vice President and Head, Intellectual Property
Eagle Pharmaceuticals, Inc.

Co-Chairs’ Opening Remarks and Recap of Day One

April 30, 2019 • 8:00 am

Members of the Judiciary

Honorable Michelle N. Ankenbrand

Lead Administrative Patent Judge
Patent Trial and Appeal Board US Patent and Trademark Office

The APJs Speak on Practice, Policy, and Procedure in the World of Pharmaceutical Patent Validity Challenges

April 30, 2019 • 1:00 pm

Honorable Tonianne J. Bongiovanni

Magistrate Judge
District of New Jersey (Trenton, NJ)

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Honorable Jacqueline Wright Bonilla

Vice Chief, Administrative
Patent Judge

The APJs Speak on Practice, Policy, and Procedure in the World of Pharmaceutical Patent Validity Challenges

April 30, 2019 • 1:00 pm

Honorable Christopher J. Burke

Magistrate Judge
District of Delaware

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Honorable Renee M. Bumb

United States District Judge
District of New Jersey

The Great Debate with District Judges

April 29, 2019 • 5:15 pm

Honorable Ruben Castillo

United States District Court
Norther District of Illinois (Chicago, IL)

The Great Debate with District Judges

April 29, 2019 • 5:15 pm

Honorable Stanley R. Chesler

United States District Judge
District of New Jersey (Newark, NJ)

The Great Debate with District Judges

April 29, 2019 • 5:15 pm

Honorable Rama G. Elluru

Administrative Patent Judge

The APJs Speak on Practice, Policy, and Procedure in the World of Pharmaceutical Patent Validity Challenges

April 30, 2019 • 1:00 pm

Honorable Kathleen M. O’Malley

United States Circuit Judge
United States Court of Appeals for the Federal Circuit (Washington, DC)

VIEW FROM THE FEDERAL CIRCUIT

April 29, 2019 • 10:30 am

Honorable Roy Payne

Magistrate Judge
Eastern District of Texas (Marshall, TX)

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Honorable Mary Pat Thynge

Chief Magistrate Judge
District of Delaware (Wilmington, DE)

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Government Representatives

Markus H. Meier

Acting Director, Bureau of Competition
Federal Trade Commission (Washington, DC)

Antitrust Developments Concerning Brands & Generics

April 30, 2019 • 11:30 am

Grail Sipes

Deputy Center Director, Regulatory Policy
CDER

Latest FDA Initiatives Affecting Generic Drug Access and Pricing

April 30, 2019 • 8:15 am

Maryll Toufanian

Director Office of Generic Drug Policy, CDER
U.S. Food & Drug Administration (Silver Spring, MD)

Latest FDA Initiatives Affecting Generic Drug Access and Pricing

April 30, 2019 • 8:15 am

In-House Counsel

Andrew Allen

Director, Legal Counsel, IP
Dr. Reddy’s Labs

Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum

April 29, 2019 • 4:15 pm

Tashica Williams Amirgholizadeh

Patent Litigation Counsel
Gilead Sciences

Brian Anderson

VP & Assistant General Counsel, IP Litigation
Allergan

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Phil Carey

Senior Counsel, Patent Litigation
Sandoz

The Business of Pharmaceutical Patent Litigation: A Global Approach

April 29, 2019 • 2:00 pm

Karen Day

Senior Counsel
Pfizer (New York, NY)

New Developments in Market Access and Exclusivities

April 30, 2019 • 9:15 am

Stephanie L. Donahue

Senior Director, Patent Litigation
Sanofi (Bridgewater, NJ)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Rekha Hanu, Ph.D, J.D

Executive Director, Chief IP Counsel
Akorn Pharmaceuticals (Lake Forest, IL)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Brian Hirsch

Vice President Global IP and Legal Head North America
Glenmark Pharmaceuticals (Mahwah, NJ)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Serge Ilin-Schneider

Serge Ilin-Schneider

General Counsel
Wockhardt USA & Morton Grove Pharmaceuticals (Troy Hills, NJ)

The Business of Pharmaceutical Patent Litigation: A Global Approach

April 29, 2019 • 2:00 pm

Lisa Jakob

Managing Counsel, Trademark Group
Merck (Rahway, NJ)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Staci Julie

SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Bruce Koch

Bruce J. Koch

Associate General Counsel, Head of Patent Litigation
Purdue Pharma L.P. (Stamford, CT)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Josephine Liu, Ph.D., J.D.

Head, US IP Litigation
Sandoz Inc. (Princeton, NJ)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Brian McCormick

Vice President – Chief Regulatory Counsel
Teva Pharmaceuticals (Horsham, PA)

New Developments in Market Access and Exclusivities

April 30, 2019 • 9:15 am

Jennifer Grant Moitoso

VP, IP
Shire

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Sam Park

U.S. General Counsel and Global Head of IP
Hikma Pharmaceuticals

The Evolving Induced Infringement Analysis

April 30, 2019 • 3:15 pm

Marck Rachlin

Senior Patent Counsel
GSK (King of Prussia, PA)

The Ethical Practice of Paragraph IV Litigation: New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena

April 30, 2019 • 4:00 pm

Colman Ragan

VP & General Counsel, North America IP Litigation
Teva Pharmaceuticals

The Practice of Pharmaceutical Patent Litigation: Part I

April 29, 2019 • 2:00 pm

Lars Taavola

Senior Patent Counsel – Global IP, Head of Patent Litigation
Amneal Pharmaceuticals

The Costs and the Consequences of Determining Venue Post-TC Heartland

April 29, 2019 • 1:00 pm

Laura A. Vogel

Senior Dir., Assoc. General Counsel of IP
Tesaro, Inc.

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Kevin Zive

VP, Global IP
Apotex (Toronto, ON)

The Business of Pharmaceutical Patent Litigation: A Global Approach

April 29, 2019 • 2:00 pm

Law Firm Attorneys

David B. Abramowitz

Partner
Locke Lord LLP (Chicago, IL)

New Developments in Market Access and Exclusivities

April 30, 2019 • 9:15 am

Richard J. Berman

Partner
Arent Fox LLP (Washington, DC)

The Costs and the Consequences of Determining Venue Post-TC Heartland

April 29, 2019 • 1:00 pm

Aziz Burgy

Partner
Axinn, Veltrop & Harkrider LLP (Washington, DC)

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Kathleen B. Carr

Partner
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

The Great Debate with District Judges

April 29, 2019 • 5:15 pm

Alan B. Clement

Partner
Locke Lord LLP (New York, NY)

Assessing Secondary Considerations in Light of Blocking Patents Post-Acorda

April 30, 2019 • 2:00 pm

David G. Conlin

Member
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (Boston, MA)

The Ethical Practice of Paragraph IV Litigation: New Developments Impacting Professional Responsibility in the Hatch-Waxman Arena

April 30, 2019 • 4:00 pm

Steven M. Coyle

Partner
Cantor Colburn LLP (Hartford, CT)

Addressing the Impact of a Uniform Claims Construction Standard: Panacea or Peril?

April 29, 2019 • 9:15 am

Carol Pitzel Cruz

Partner
Knobbe Martens (Seattle, WA)
Bo Davis

Bo Davis

Founding Partner
The Davis Firm (Longview, TX)

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Daniel DiNapoli

Daniel P. DiNapoli

Partner
Arnold & Porter LLP (New York, NY)

The Practice of Pharmaceutical Patent Litigation: Part I

April 29, 2019 • 2:00 pm

Michael Dougherty

Partner
DLA Piper (New York, NY)

The Evolving Induced Infringement Analysis

April 30, 2019 • 3:15 pm

Laura Fairneny

Partner
Quinn Emanuel Urquhart & Sullivan, LLP (New York, NY)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Gerald J. Flattmann Jr.

Partner
King & Spalding (New York, NY)

Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum

April 29, 2019 • 4:15 pm

Christine I. Gannon

Partner
Walsh Pizzi O’Reilly Falanga LLP (Newark, NJ)

Jeffrey R. Gargano

Partner
Morgan, Lewis & Bockius LLP (Chicago, IL)

Parallel Proceedings Master Class

May 1, 2019 • 1:00 pm

Anne Shea Gaza

Partner
Young Conaway Stargartt & Taylor, LLP (Wilmington, DE)

A Town Hall with the Magistrate Judges*

April 30, 2019 • 9:15 am

Barry P. Golob

Co-Chair, Intellectual Property Litigation
Cozen O’Connor

The Great Debate with District Judges

April 29, 2019 • 5:15 pm

Taras A. Gracey

Shareholder
Polsinelli PC (Chicago, IL)

The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses

April 29, 2019 • 8:15 am

Vishal C. Gupta

Partner
Steptoe & Johnson LLP (New York, NY)

The Practice of Pharmaceutical Patent Litigation: Part I

April 29, 2019 • 2:00 pm

John T. Gutkoski

Partner
McCarter & English, LLP (Boston, MA)

Sheldon Hamilton

Partner
Smart & Biggar Fetherstonhaugh (Toronto, ON)

The Practice of Pharmaceutical Patent Litigation: Part I

April 29, 2019 • 2:00 pm

Gary E. Hood

Shareholder, IP Division Chair
Polsinelli PC (Chicago, IL)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Benjamin C. Hsing

Partner
McGuire Woods (New York, NY)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Charlotte Jacobsen

Partner
Ropes & Gray LLP (New York, NY)

The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses

April 29, 2019 • 8:15 am

Michael P. Kahn

Partner
Akin Gump Strauss Hauer & Feld LLP (New York, NY)

Addressing the Impact of a Uniform Claims Construction Standard: Panacea or Peril?

April 29, 2019 • 9:15 am

Scott E. Kamholz

Of Counsel
Covington & Burling LLP (Washington, DC)

Kurt R. Karst

Director
Hyman, Phelps & McNamara PC (Washington, DC)

Ben Katzenellenbogen

Partner
Knobbe Martens (Irvine, CA)

The Supreme Court Weighs in on the On- Sale Bar and the State of Secret Prior Art

April 29, 2019 • 11:00 am

Nathaniel Lipkus

Partner
Osler, Hoskin & Harcourt LLP

The Business of Pharmaceutical Patent Litigation: A Global Approach

April 29, 2019 • 2:00 pm

Aaron Lukas

Member
Cozen O’Connor (Washington, DC)

Addressing the Impact of a Uniform Claims Construction Standard: Panacea or Peril?

April 29, 2019 • 9:15 am

Emily Marden

Counsel
Sidley Austin LLP

New Developments in Market Access and Exclusivities

April 30, 2019 • 9:15 am

Christie Matthaei

Partner
Knobbe Martens (Seattle, WA)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Daniel J. Minion

Partner
Fitzpatrick, Cella, Harper & Scinto

The Evolving Induced Infringement Analysis

April 30, 2019 • 3:15 pm

John Molenda

Partner
Steptoe & Johnson LLP (New York, NY)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Gregory A. Morris

Partner
Honigman LLP (Chicago, IL)

The Costs and the Consequences of Determining Venue Post-TC Heartland

April 29, 2019 • 1:00 pm

Deepro R. Mukerjee

Partner
KattenMuchinRosenman LLP (New York, NY)

The Business of Pharmaceutical Patent Litigation: A Global Approach

April 29, 2019 • 2:00 pm

Huong Nguyen

Partner
Litwin Law LLC (Oakland, CA)

The Practice of Pharmaceutical Patent Litigation: Part I

April 29, 2019 • 2:00 pm

Kevin E. Noonan

Partner
McDonnell Boehnen Hulbert & Berghoff LLP (Chicago, IL)

Working Group on Biosimilars for the Hatch-Waxman Practitioner

May 1, 2019 • 8:30 am

Joseph O’Malley

Partner
Paul Hastings LLP (New York, NY)

The Supreme Court Weighs in on the On- Sale Bar and the State of Secret Prior Art

April 29, 2019 • 11:00 am

Sapna W. Palla

Partner
Wiggin and Dana (New York, NY)

New Developments in Market Access and Exclusivities

April 30, 2019 • 9:15 am

Matthew A. Pearson

Partner
Akin Gump Strauss Hauer & Feld LLP (Philadelphia, PA)

Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum

April 29, 2019 • 4:15 pm

Lisa B. Pensabene

Partner
O’Melveny & Myers LLP (New York, NY)

The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses

April 29, 2019 • 8:15 am

Liane M. Peterson

Partner
Foley & Lardner LLP (Washington, DC)

Assessing Secondary Considerations in Light of Blocking Patents Post-Acorda

April 30, 2019 • 2:00 pm

Filko Prugo

Partner
Ropes & Gray LLP (New York, NY)

The Evolving Induced Infringement Analysis

April 30, 2019 • 3:15 pm

Stephen S. Rabinowitz

Partner
Dechert LLP (New York, NY)

The Supreme Court Weighs in on the On- Sale Bar and the State of Secret Prior Art

April 29, 2019 • 11:00 am

Teresa Rea

Hon. Teresa Rea

Partner
Crowell & Moring LLP
(Former Acting Under Secretary of Commerce for Intellectual Property and Former Acting Director of the United States Patent and Trademark Office) (Washington, DC)

New Developments in Market Access and Exclusivities

April 30, 2019 • 9:15 am

Robert Rhoad

Partner
Dechert LLP

Hassen A. Sayeed M.D.

Partner
O’Melveny & Myers LLP (New York, NY)

ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*

April 29, 2019 • 2:00 pm

Christina Schwarz

Partner
Venable LLP (New York, NY)

The Present State of Paragraph IV Litigation and Its Impact on the Pharmaceutical Industry: Legal Analyses and Business Prognoses

April 29, 2019 • 8:15 am

David Silverstein

Partner
Axinn, Veltrop & Harkrider LLP (New York, NY)

The Business of Pharmaceutical Patent Litigation: A Global Approach

April 29, 2019 • 2:00 pm

Steven H. Sklar

Shareholder
Leydig, Voit & Mayer Ltd. (Chicago, IL)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Dennies Varughese

Dennies Varughese

Director
Sterne Kessler Goldstein & Fox (Washington, DC)

Assessing Secondary Considerations in Light of Blocking Patents Post-Acorda

April 30, 2019 • 2:00 pm

Jeanna M. Wacker

Partner
Kirkland & Ellis LLP (New York, NY)

The Practice of Pharmaceutical Patent Litigation: Part II

April 30, 2019 • 9:15 am

Mark E. Waddell

Co-Chair, Life Sciences
Loeb & Loeb LLP (New York, NY)

Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum

April 29, 2019 • 4:15 pm

Bruce M. Wexler

Partner
Paul Hastings LLP (New York, NY)

Subject Matter Patentability and Written Description Reconsidered: Understanding the New §101 and §112 Conundrum

April 29, 2019 • 4:15 pm

Jovial Wong

Partner
Winston & Strawn LLP (Washington, DC)

The Supreme Court Weighs in on the On- Sale Bar and the State of Secret Prior Art

April 29, 2019 • 11:00 am